PUTNAM INVESTMENTS LLC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 40 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q4 2017$12,466,000
+99.4%
10,524,000
+101.5%
0.01%0.0%
Q3 2017$6,253,000
+11.3%
5,224,000
+10.6%
0.01%
+7.7%
Q2 2017$5,618,000
+0.7%
4,724,0000.0%0.01%0.0%
Q1 2017$5,577,000
-29.0%
4,724,000
-29.5%
0.01%
-31.6%
Q4 2016$7,851,000
+8.7%
6,700,000
+15.6%
0.02%
+11.8%
Q3 2016$7,225,000
+23.9%
5,794,000
+14.9%
0.02%
+21.4%
Q2 2016$5,829,000
-25.1%
5,042,000
-23.2%
0.01%
-22.2%
Q1 2016$7,784,000
-20.1%
6,565,000
-9.9%
0.02%
-18.2%
Q4 2015$9,740,000
-5.0%
7,289,000
-4.3%
0.02%
-4.3%
Q3 2015$10,254,000
-0.9%
7,616,000
+17.3%
0.02%
+9.5%
Q2 2015$10,343,000
-23.6%
6,495,000
-27.7%
0.02%
-22.2%
Q1 2015$13,544,000
-2.6%
8,984,000
-20.8%
0.03%
-6.9%
Q4 2014$13,903,000
+20.4%
11,344,000
+7.5%
0.03%
+20.8%
Q3 2014$11,551,000
+20.0%
10,549,000
+15.4%
0.02%
+14.3%
Q2 2014$9,624,000
+9.4%
9,139,000
+15.3%
0.02%
+5.0%
Q1 2014$8,796,000
+174.2%
7,924,000
+164.1%
0.02%
+150.0%
Q4 2013$3,208,0003,000,0000.01%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q3 2017
NameSharesValueWeighting ↓
Birch Grove Capital LP 5,000,000$5,003,0002.71%
Weiss Asset Management LP 65,841,000$64,360,0002.62%
Davide Leone & Partners Investment Co Ltd. 10,500,000$10,513,0001.19%
TENOR CAPITAL MANAGEMENT Co., L.P. 29,597,000$29,800,0001.14%
GLAZER CAPITAL, LLC 7,483,000$7,474,0000.36%
BLUEFIN CAPITAL MANAGEMENT, LLC 52,500$5,243,0000.33%
OAKTREE CAPITAL MANAGEMENT LP 13,428,000$13,444,0000.29%
CSS LLC/IL 5,500,000$5,498,0000.26%
Kohlberg Kravis Roberts & Co. L.P. 40,182,000$40,159,0000.23%
EDMOND DE ROTHSCHILD HOLDING S.A. 2,606,000$2,606,0000.10%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders